In a recent Contract Pharma roundtable, industry leaders discussed the key trends impacting CDMOs in 2025 and beyond. Our very own CCO, Henny Zijlstra, contributed her expertise to the conversation, highlighting three critical areas that CDMOs need to address this year.
Henny dives into:
- Consolidation of CDMO networks: Exploring how mergers and acquisitions are reshaping the landscape.
- Client-centric digitalization: Examining the importance of digital tools in enhancing client relationships and project management.
- Continued onshoring of projects: Analyzing the drivers behind the reshoring trend and its implications for CDMOs.
Want to understand how these trends will impact your pharmaceutical development and manufacturing strategies? Read Henny’s full insights and the complete roundtable discussion on Contract Pharma: https://www.contractpharma.com/cdmos-key-leader-insights/
